Hypnosis for treatment of HIV neuropathic pain: A preliminary report

Pain Medicine (United States)

Volumn 14, Issue 7, 2013, Pages 1048-1056

  Dorfman, David ^a   George, Mary Catherine ^a   Schnur, Julie ^a   Simpson, David M ^a   Davidson, George ^a   Montgomery, Guy ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

HIV; Hypnosis; Neuropathy; Pain

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIRETROVIRUS AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE;

AFFECT; AFRICAN AMERICAN; ANALGESIA; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPNOSIS; MCGILL PAIN QUESTIONNAIRE; NEUROPATHIC PAIN; PAIN ASSESSMENT; PROSPECTIVE STUDY; QUALITY OF LIFE; TREATMENT DURATION; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

EID: 84880579251     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/pme.12074     Document Type: Article

References (39)

1. Ellis RJ, Rosario D, Clifford DB, etal. Continued high prevalence and adverse clinical impact of high immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy. Arch Neurol 2010;67:552-558.
2. Robinson-Papp J, Simpson D. Neuromuscular complications of Human Immunodeficiency Virus infection. Phys Med Rehabil Clin N Am 2008;19:81-96.
3. Robinson-Papp J, Gonzalez-Duarte A, Simpson DM, Rivera-Mindt M, Morgello S; Manhattan HIV Brain Bank. The roles of ethnicity and antiretrovirals in HIV-associated polyneuropathy: A pilot study. J Acquir Immune Defic Syndr 2009;51:569-573.
4. Phillips TJC, Cherry CL, Moss PJ, Rice ASC. Painful HIV-associated neuropathy. Pain Clin Updat 2010;18:1-8.
5. Simpson DM, Tagliati M. Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection. J AIDS 1995;9:153-161.
6. Verma S, Micsa E, Estanislao L, Simpson D. HIV Neuropathy. Curr Neurol Neurosci Rep 2004;4:62-67.
7. Wulff E, Wang A, Simpson D. HIV-associated peripheral neuropathy: Epidemiology, pathophysiology and treatment. Drugs 2000;59:1251-1260.
8. Breitbart W, McDonald M, Rosenfeld B, etal. Pain in ambulatory AIDS patients-I: Pain characteristics and medical correlates. Pain 1996;58:315-321.
9. Rosenfeld B, Breitbart W, McDonald M, etal. Pain in ambulatory AIDS patients-II: Impact of pain on psychological functioning and quality of life. Pain 1996;68:323-328.
10. Finnerup NB, Sindrup SH, Jensen TS. The evidence for pharmacological treatment of neuropathic pain. Pain 2010;150:573-581.
11. Phillips TJC, Cherry CL, Cox S, Marshall SJ, Rice ASC. Pharmacological treatment of painful HIV-associated sensory neuropathy: A systematic review and meta-analysis of randomised controlled trials. Plos ONE 2010;5(12):e14433.
12. Montgomery G, DuHamel K, Redd W. A meta-analysis of hypnotically induced analgesia: How effective is hypnosis? Int J Clin Exp Hypn 2000;48:138-153.
13. Patterson R, Jensen M. Hypnosis and clinical pain. Psychol Bull 2003;129:495-521.
14. Lewis D. Hypnoanalgesia for chronic pain: The response to multiple inductions at one session and to separate single inductions. J R Soc Med 1992;85:620-624.
15. Montgomery G, Weltz C, Seltz M, Bovbjerg D. Brief pre-surgery hypnosis reduces distress and pain in excisional breast biopsy patients. Int J Clin Exp Hypn 2002;50:17-32.
16. Montgomery GH, Bovbjerg DH, Schnur JB, etal. A randomized clinical trial of a brief hypnosis intervention to control side effects in breast surgery patients. J Natl Cancer Inst 2007;99:1304-1312.
17. Lang EV, Rosen MP. Cost analysis of adjunct hypnosis with sedation during outpatient interventional radiologic procedures. Radiology 2002;222:375-382.
18. Edelson J, Fitzpatrick JL. A comparison of cognitive-behavioral and hypnotic treatments of chronic pain. J Clin Psychol 1989;45:316-323.
19. Elkins G, Jensen MP, Patterson DR. Hypnotherapy for the management of chronic pain. Int J Clin Exp Hypn 2007;55:275-287.
20. Jensen M, Patterson DR. Hypnotic treatment of chronic pain. J Behav Med 2006;29:95-124.
21. Haanen HC, Hoenderdos HT, van Romunde LK, etal. Controlled trial of hypnotherapy in the treatment of refractory fibromyalgia. J Rheumatol 1991;18:72-75.
22. Dworkin R, Backonja M, Rowbothan M, etal. Advances in neuropathic pain: Diagnosis, mechanisms, and treatment recommendations. Arch Neurol 2003;60:1524-1534.
23. Turk DC, Dworkin RH, Allen RR, etal. Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain 2003;106:337-345.
24. Turk DC, Dworkin RH, Revicki D, etal. Identifying important outcome domains for chronic pain clinical trials: An IMMPACT survey of people with pain. Pain 2008;137:276-285.
25. Melzack R. The short-form McGill Pain Questionnaire. Pain 1987;30:191-197.
26. Katz J, Melzack R. The McGill Pain Questionnaire: Development, psychometric properties, and usefulness of the Long Form, Short Form, and Short Form-2. In: Turk D, Melzack R, eds. Handbook of Pain Assessment, 3rd edition. New York: The Guilford Press; 2011:45-66.
27. Backonja M, Beydoun A, Edwards KR, etal. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomized controlled trial. J Am Med Assoc 1998;280:1831-1836.
28. Gilron I, Bailey JM, Tu D, etal. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005;352:1324-1334.
29. Dworkin RH, Corbin AE, Young JP, etal. Pregabalin for the treatment of postherpetic neuralgia: A randomized, placebo-controlled trial. Neurology 2003;60:1274-1283.
30. Radloff LS. The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385-401.
31. Spielberger C. State-Trait Anxiety Inventory. Redwood City, CA: Mind Garden; 1981.
32. Wu AW, Revicki DA, Jacobson D, Malitz FE. Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV). Qual Life Res 1997;6:481-493.
33. Ware J, Sherburne C. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care 1992;30:473-483.
34. Keppel G. Design and Analysis: A Researcher's Handbook, 3rd edition. Englewood Cliffs, NJ: Prentice-Hall; 1991.
35. Kirk R. Experimental Design: Procedures for the Behavioral Sciences, 2nd edition. Pacific Grove, CA: Brooks/Cole Publishing Company; 1982.
36. Hill AB. Principles of Medical Statistics, 7th edition. London: The Lancet Limited; 1961.
37. Cohen J. Statistical Power Analysis for the Behavioral Sciences, 2nd edition. Hillsdale, NJ: Erlbaum; 1988.
38. Willke RJ, Burke LB, Erickson P. Measuring treatment impact: A review of patient-reported outcomes and other efficacy endpoints in approved product labels. Control Clin Trials 2004;25:535-552.
39. Turk DC, Dworkin RH, Burke LB, etal. Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendations. Pain 2006;125:208-215.